All Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial Articles
-
619Latest Myopia NewsVTI Shares Preliminary Two-Year Data from PROTECT Study
January 17, 2025 LAS VEGAS — Visioneering Technologies Inc. (VTI) has shared the preliminary two-year findings from its ongoing PROTECT (PROgressive Myopia...
-
1.0KClinicalLearnings from the NaturalVue Multifocal PROTECT RCT 1-Year Dataset
sponsored content January 2, 2025 By Brett O’Connor, OD, FAAO With myopia reaching epidemic proportions in countries around the world, eye care...
-
825Products & ServicesVTI Shares New Findings from its PROTECT Study of the NaturalVue Multifocal Contact Lens
sponsored content December 16, 2024 Recently discovered findings continue emerging from the PROTECT RCT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) being conducted by Visioneering...
-
699Products & ServicesVTI’s Chief Medical Officer Dr. Ashley Tuan Shares PROTECT Study Data at IMC
sponsored content October 15, 2024 SANYA, Hainan Island, China – Dr. Ashley Tuan, OD, PhD, the Chief Medical Officer of Visioneering Technologies,...
-
542Latest Myopia NewsVTI Presents Latest PROTECT Trial Data at Myopia Conferences
October 7, 2024 HAINAN ISLAND, China, and DALLAS, Texas — Visioneering Technologies Inc. (VTI) has presented the latest data from its PROTECT...
-
1.5KLatest Myopia NewsVTI Shares Latest Data From PROTECT Study at ARVO 2024
May 6, 2024 SEATTLE, Wash. — Visioneering Technologies Inc. has shared the latest data from its PROTECT (PROgressive Myopia Treatment Evaluation for...
-
1.0KProducts & ServicesVTI’s Dr. Ashley Tuan Shares PROTECT Study’s One-Year Results
sponsored content March 4, 2024 In this video, Visioneering Technologies, Inc.’s Chief Medical Officer Dr. Ashley Tuan shares the one-year results of the...
-
933Latest Myopia NewsVTI Shares Ongoing Results of One-Year PROTECT Trial
January 22, 2024 LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation...
-
912Clinical
PROTECT Preliminary Trial Data Supports Safety and Efficacy of NaturalVue Multifocal 1 Day for Myopia Progression Control
sponsored content December 1, 2023 The presentation at the 2023 meeting of the American Academy of Optometry, “Seeing Is Believing: NaturalVue Multifocal...
-
903Products & ServicesJuan Carlos Aragón Discusses His New CEO Role at Visioneering Technologies
sponsored content October 12, 2023 At the American Academy of Optometry’s Annual Meeting, Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Dr. Juan...
-
907Latest Myopia NewsVTI Shares One-Year Data from PROTECT Trial at AAO 2023
October 12, 2023 NEW ORLEANS, La. — At the 2023 American Academy of Optometry meeting held here, Visioneering Technologies Inc. shared interim...
-
1.5KClinicalVTI’s CMO Dr. Ashley Tuan On NaturalVue and the PROTECT Study
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...